Xwell (XWEL) Total Non-Current Liabilities (2010 - 2025)

Xwell (XWEL) posted Total Non-Current Liabilities of $17.5 million for Q3 2025, up 1.49% sequentially from $17.3 million in Q2 2025.

Xwell (XWEL) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Xwell has reported Total Non-Current Liabilities for 12 years, with the latest figure at $17.5 million in Q3 2025.

Quarterly Total Non-Current Liabilities changed N/A year-over-year to $17.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $17.5 million (changed N/A YoY) and the FY2020 annual result came in at $7.4 million, down 73.8% from the prior year.
Total Non-Current Liabilities advanced to $17.5 million in Q3 2025 per XWEL's latest filing, from $17.3 million in the prior quarter.
Over five years, Total Non-Current Liabilities peaked at $18.1 million in Q1 2025 and troughed at $17.3 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	108.64 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	85.84 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	542.10 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	5.45 Bn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	22.94 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	737.18 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	6.36 Bn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	3.39 Bn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	15.88 Bn
10	Xwell	7.47 Mn	-9.34 Mn	2.35 Mn	-

Download Data